FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joel Moss

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Cloning, Molecular

Co-author Network

Publications

TOP 3
Sisi Lin; Peiqing Liu; Zhi-Ping Liu; Liang Lu; Joel Moss; Edward Neufeld; Shaorui Chen; Heqing Huang; Kang Le; Cuixian Li; Dong Li; Martha Vaughan; Ying Wang; Yu-Hua Wang; Suo-Wen Xu; Chun Zhou; Xiaoyan Shen
BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function.
Francis X McCormack; Thomas V Colby; Elizabeth P Henske; William D Travis; Joel Moss
Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm.
Xiaoyan Shen; Angel M Aponte; Eric M Billings; Chun-Chun Li; Joel Moss; Rong-Fong Shen; Martha Vaughan
Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joel Moss (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sisi Lin; Peiqing Liu; Zhi-Ping Liu; Liang Lu; Joel Moss; Edward Neufeld; Shaorui Chen; Heqing Huang; Kang Le; Cuixian Li; Dong Li; Martha Vaughan; Ying Wang; Yu-Hua Wang; Suo-Wen Xu; Chun Zhou; Xiaoyan Shen
BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(2):e31-8.
2012: Francis X McCormack; Thomas V Colby; Elizabeth P Henske; William D Travis; Joel Moss
Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm.
American journal of respiratory and critical care medicine 2012;186(12):1210-2.
2012: Xiaoyan Shen; Angel M Aponte; Eric M Billings; Chun-Chun Li; Joel Moss; Rong-Fong Shen; Martha Vaughan
Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(36):14464-9.
2012: Connie G Glasgow; Souheil El-Chemaly; Joel Moss
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.
European respiratory review : an official journal of the European Respiratory Society 2012;21(125):196-206.
2012: Sergio Harari; Angelo M Taveira-DaSilva; Olga Torre; Roberto Cassandro; Joel Moss
Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis.
Respiratory medicine 2012;106(9):1286-92.
2012: Angelo M Taveira-DaSilva; Joel Moss
Optimizing treatments for lymphangioleiomyomatosis.
Expert review of respiratory medicine 2012;6(3):267-76.
2012: Angelo M Taveira-DaSilva; Joel Moss
Progress in the treatment of lymphangioleiomyomatosis: from bench to bedside.
Revista portuguesa de pneumologia 2012;18(3):142-4.
2012: Kang Le; Cuixian Li; Ruifang Li; Yingxia Bao; Yi Cai; Heqing Huang; Tian Lan; Joel Moss; Xiaoyan Shen; Xiaoqian Wu; Suowen Xu; Jian Zou; Peiqing Liu
PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Archives of biochemistry and biophysics 2012;518(1):71-8.
2012: Karin Fredriksson; Karen J Keeran; Arnold S Kristof; Jonathan K Lam; Katharine S Meyer; Joel Moss; Xuan Qu; Xianglan Yao; Zu-Xi Yu; Gayle J Zywicke; Jill A Fielhaber; Stewart J Levine
Paradoxical effects of rapamycin on experimental house dust mite-induced asthma.
PloS one 2012;7(5):e33984.
2011: Chun-Chun Li; Joel Moss; Ryoiti Kiyama; Jean-Cheng Kuo; Clare M Waterman; Martha Vaughan
Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(48):19228-33.
2011: Angelo M Taveira-DaSilva; Antoinette Rabel; Nilo A Avila; Bernadette R Gochuico; Joel Moss
Prevalence of uterine leiomyomas in lymphangioleiomyomatosis.
Fertility and sterility 2011;96(3):711-714.e1.
2011: Joel Moss
Ahead of the curve.
Chest 2011;140(2):275-6.
2011: Victor Meza-Carmen; Joel Moss; Gustavo Pacheco-Rodriguez; D Michael Payne; Mario Stylianou; Chiara Donati; Souheil El-Chemaly; Gi Soo Kang; Jiro Kato; Alessandro Vichi; Chun-Yi Zhang; Martha Vaughan
Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(26):10454-9.
2011: Diane Seibert; Fumiko Takeuchi; Olanda M Hathaway; Chien-Hui Hong; Joel Moss; Cara Olsen; Thomas Darling
Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences.
Annals of internal medicine 2011;154(12):806-13, W-294.
2011: Angelo M Taveira-DaSilva; Mario Stylianou; Olanda M Hathaway; Joel Moss
Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
Annals of internal medicine 2011;154(12):797-805, W-292-3.
2011: Atsushi Kasamatsu; Jiro Kato; Lindsay R Comstock; John M Denu; Motoyuki Nakao; Tohru Ono; Brian C Smith; Joel Moss
Hydrolysis of O-acetyl-ADP-ribose isomers by ADP-ribosylhydrolase 3.
The Journal of biological chemistry 2011;286(24):21110-7.
2011: Shaowei Li; Rajesh L Thangapazham; Ji-an Wang; Sangeetha Rajesh; Tzu-Cheg Kao; Leonard Sperling; Joel Moss; Thomas Darling
Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis.
Nature communications 2011;2():235.
2011: Yoshihiko Ikeda; Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Souheil El-Chemaly; Bernadette R Gochuico; Rose M May; Olanda M Hathaway; Shaowei Li; Ji-an Wang; Thomas Darling; Mario Stylianou; Joel Moss
Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.
American journal of physiology. Lung cellular and molecular physiology 2011;300(1):L64-72.
2010: Xiong Cai; Gustavo Pacheco-Rodriguez; Qing-Yuan Fan; Mary Haughey; Leigh Samsel; Souheil El-Chemaly; Hai-Ping Wu; J Philip McCoy; Wendy K Steagall; Jing-Ping Lin; Thomas Darling; Joel Moss
Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.
American journal of respiratory and critical care medicine 2010;182(11):1410-8.
2010: Yasuhiro Terasaki; Kinnosuke Yahiro; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Mario P Stylianou; Jilly F Evans; Ameae M Walker; Joel Moss
Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis.
American journal of respiratory and critical care medicine 2010;182(4):531-9.
2010: Capt Shelley L Aldrich; Chien-Hui Hong; Leslie Groves; Cara Olsen; Joel Moss; Thomas Darling
Acral lesions in tuberous sclerosis complex: insights into pathogenesis.
Journal of the American Academy of Dermatology 2010;63(2):244-51.
2010: Connie G Glasgow; Wendy K Steagall; Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Xiong Cai; Souheil El-Chemaly; Marsha Moses; Thomas Darling; Joel Moss
Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.
Respiratory medicine 2010;104 Suppl 1():S45-58.
2010: Thomas Darling; Gustavo Pacheco-Rodriguez; Alfredo Gorio; Elena Lesma; Cheryl Walker; Joel Moss
Lymphangioleiomyomatosis and TSC2-/- cells.
Lymphatic research and biology 2010;8(1):59-69.
2010: Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Joel Moss
The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.
Lymphatic research and biology 2010;8(1):9-19.
2010: Joel Moss
Focus on Lymphangioleiomyomatosis. Introduction.
Lymphatic research and biology 2010;8(1):3.
2010: Gustavo Pacheco-Rodriguez; Joel Moss
The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.
Critical reviews in immunology 2010;30(4):387-94.
2009: Connie G Glasgow; Angelo Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Katsuya Tsukada; Xiong Cai; Souheil El-Chemaly; Joel Moss
Involvement of lymphatics in lymphangioleiomyomatosis.
Lymphatic research and biology 2009;7(4):221-8.
2009: Souheil El-Chemaly; Gustavo Pacheco-Rodriguez; Yoshihiko Ikeda; Daniela Malide; Joel Moss
Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.
Lymphatic research and biology 2009;7(4):197-203.
2009: Angelo M Taveira-DaSilva; Wendy K Steagall; Antoinette Rabel; Olanda M Hathaway; Sergio Harari; Roberto Cassandro; Mario Stylianou; Joel Moss
Reversible airflow obstruction in lymphangioleiomyomatosis.
Chest 2009;136(6):1596-603.
2009: Angelo M Taveira-DaSilva; Dara Burstein; Olanda M Hathaway; Joseph R Fontana; Bernadette R Gochuico; Nilo A Avila; Joel Moss
Pneumothorax after air travel in lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, and sarcoidosis.
Chest 2009;136(3):665-70.
2009: M K Park; H Babaali; L I Gilbert-McClain; M Stylianou; J Joo; Joel Moss; Vincent C Manganiello
Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2009;26(2):121-31.
2009: Connie G Glasgow; Nilo A Avila; Jing-Ping Lin; Mario Stylianou; Joel Moss
Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.
Chest 2009;135(5):1293-300.
2009: Ermanno Puxeddu; Marina Uhart; Chun-Chun Li; Faiyaz Ahmad; Gustavo Pacheco-Rodriguez; Vincent C Manganiello; Joel Moss; Martha Vaughan
Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(15):6158-63.
2009: Souheil El-Chemaly; Daniela Malide; Enrique Zudaire; Yoshihiko Ikeda; Benjamin A Weinberg; Gustavo Pacheco-Rodriguez; Ivan O Rosas; Marta Aparicio; Ping Ren; Sandra D MacDonald; Hai-Ping Wu; Steven D Nathan; Frank Cuttitta; J Philip McCoy; Bernadette R Gochuico; Joel Moss
Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(10):3958-63.
2009: Gustavo Pacheco-Rodriguez; Fumiyuki Kumaki; Wendy K Steagall; Yi Zhang; Yoshihiko Ikeda; Jing-Ping Lin; Eric M Billings; Joel Moss
Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(3):1270-7.
2009: Angelo M Taveira-DaSilva; Wendy K Steagall; Joel Moss
Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going.
F1000 medicine reports 2009;1():.
2008: Xiaoyan Shen; Victor Meza-Carmen; Ermanno Puxeddu; Guanghui Wang; Joel Moss; Martha Vaughan
Interaction of brefeldin A-inhibited guanine nucleotide-exchange protein (BIG) 1 and kinesin motor protein KIF21A.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(48):18788-93.
2008: Aminul Islam; Heather Jones; Toyoko Hiroi; Jonathan Lam; Jing Zhang; Joel Moss; Martha Vaughan; Stewart J Levine
cAMP-dependent protein kinase A (PKA) signaling induces TNFR1 exosome-like vesicle release via anchoring of PKA regulatory subunit RIIbeta to BIG2.
The Journal of biological chemistry 2008;283(37):25364-71.
2008: Philip Ian Padilla; Marina Uhart; Gustavo Pacheco-Rodriguez; Brenda A Peculis; Joel Moss; Martha Vaughan
Association of guanine nucleotide-exchange protein BIG1 in HepG2 cell nuclei with nucleolin, U3 snoRNA, and fibrillarin.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(9):3357-61.
2008: Shaowei Li; Fumiko Takeuchi; Ji-an Wang; Qingyuan Fan; Toshi Komurasaki; Eric M Billings; Gustavo Pacheco-Rodriguez; Joel Moss; Thomas Darling
Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(9):3539-44.
2008: Carmen Citterio; Alessandro Vichi; Gustavo Pacheco-Rodriguez; Angel M Aponte; Joel Moss; Martha Vaughan
Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(8):2877-82.
2008: Sergio Harari; Roberto Cassandro; Iacopo Chiodini; Jacopo Chiodini; Angelo M Taveira-DaSilva; Joel Moss
Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.
Chest 2008;133(2):448-54.
2008: Connie G Glasgow; Angelo M Taveira-DaSilva; Thomas Darling; Joel Moss
Lymphatic involvement in lymphangioleiomyomatosis.
Annals of the New York Academy of Sciences 2008;1131():206-14.
2008: Souheil El-Chemaly; Stewart J Levine; Joel Moss
Lymphatics in lung disease.
Annals of the New York Academy of Sciences 2008;1131():195-202.
2007: Janet R Maurer; Jay Ryu; Gerald Beck; Joel Moss; Jar-Chi Lee; Geraldine A Finlay; Kevin Brown; Jeffrey Chapman; June McMahan; Eric Olson; Stephen J Ruoss; Susan Sherer
Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2007;26(12):1293-9.
2007: Gustavo Pacheco-Rodriguez; Wendy K Steagall; Denise Crooks; Linda A Stevens; Hiroshi Hashimoto; Shaowei Li; Ji-an Wang; Thomas Darling; Joel Moss
TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.
Cancer research 2007;67(21):10573-81.
2007: Angelo M Taveira-DaSilva; Olanda M Hathaway; Vandana Sachdev; Yukitaka Shizukuda; Charles W Birdsall; Joel Moss
Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.
Chest 2007;132(5):1573-8.
2007: Chun-Chun Li; Tsai-Chen Chiang; Tsung-Sheng Wu; Gustavo Pacheco-Rodriguez; Joel Moss; Fang-Jen S Lee
ARL4D recruits cytohesin-2/ARNO to modulate actin remodeling.
Molecular biology of the cell 2007;18(11):4420-37.
2007: Wendy K Steagall; Connie G Glasgow; Olanda M Hathaway; Nilo A Avila; Angelo M Taveira-DaSilva; Antoinette Rabel; Mario Stylianou; Jing-Ping Lin; Xiaoling Chen; Joel Moss
Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis.
American journal of physiology. Lung cellular and molecular physiology 2007;293(3):L800-8.
2007: Jiro Kato; Jianfeng Zhu; Chengyu Liu; Joel Moss
Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice.
Molecular and cellular biology 2007;27(15):5534-43.
2007: Wendy K Steagall; Bethany J Barrow; Connie G Glasgow; Jennifer Woo Mendoza; Mary Ehrmantraut; Jing-Ping Lin; Paul A Insel; Joel Moss
Beta-2-adrenergic receptor polymorphisms in cystic fibrosis.
Pharmacogenetics and genomics 2007;17(6):425-30.
2007: Aminul Islam; Xiaoyan Shen; Toyoko Hiroi; Joel Moss; Martha Vaughan; Stewart J Levine
The brefeldin A-inhibited guanine nucleotide-exchange protein, BIG2, regulates the constitutive release of TNFR1 exosome-like vesicles.
The Journal of biological chemistry 2007;282(13):9591-9.
2007: Fuminobu Kuroda; Joel Moss; Martha Vaughan
Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3201-6.
2007: Wendy K Steagall; Jing-Ping Lin; Joel Moss
The C/A(-18) polymorphism in the surfactant protein B gene influences transcription and protein levels of surfactant protein B.
American journal of physiology. Lung cellular and molecular physiology 2007;292(2):L448-53.
2007: Xiaoyan Shen; Myoung-Soon S Hong; Joel Moss; Martha Vaughan
BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(4):1230-5.
2007: Nilo A Avila; Andrew J Dwyer; Antoinette Rabel; Joel Moss
Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features.
Radiology 2007;242(1):277-85.
2006: Tohru Ono; Atsushi Kasamatsu; Shunya Oka; Joel Moss
The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(45):16687-91.
2006: Alan R Morrison; Joel Moss; Linda A Stevens; James E Evans; Caitlin Farrell; Eric Merithew; David G Lambright; Dale L Greiner; John P Mordes; Aldo A Rossini; Rita Bortell
ART2, a T cell surface mono-ADP-ribosyltransferase, generates extracellular poly(ADP-ribose).
The Journal of biological chemistry 2006;281(44):33363-72.
2006: Angelo M Taveira-DaSilva; Wendy K Steagall; Joel Moss
Lymphangioleiomyomatosis.
Cancer control : journal of the Moffitt Cancer Center 2006;13(4):276-85.
2006: Arnold S Kristof; Jill Fielhaber; Alexandra Triantafillopoulos; Shino Nemoto; Joel Moss
Phosphatidylinositol 3-kinase-dependent suppression of the human inducible nitric-oxide synthase promoter is mediated by FKHRL1.
The Journal of biological chemistry 2006;281(33):23958-68.
2006: Toyoko Hiroi; Akimasa Someya; Walter Thompson; Joel Moss; Martha Vaughan
GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(28):10672-7.
2006: Julio C Valencia; Gustavo Pacheco-Rodriguez; Adriana K Carmona; Janina Xavier; Patrick Bruneval; William K Riemenschneider; Yoshihiko Ikeda; Zu-Xi Yu; Victor J Ferrans; Joel Moss
Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
American journal of respiratory cell and molecular biology 2006;35(1):40-7.
2006: Xuexiu Zheng; Alan R Morrison; An-Sik Chung; Joel Moss; Rita Bortell
Substrate specificity of soluble and membrane-associated ADP-ribosyltransferase ART2.1.
Journal of cellular biochemistry 2006;98(4):851-60.
2006: Gregorino Paone; Linda A Stevens; Rodney L Levine; Christelle Bourgeois; Wendy K Steagall; Bernadette R Gochuico; Joel Moss
ADP-ribosyltransferase-specific modification of human neutrophil peptide-1.
The Journal of biological chemistry 2006;281(25):17054-60.
2006: Nilo A Avila; Andrew J Dwyer; Antoinette Rabel; Rosamma M DeCastro; Joel Moss
CT of pleural abnormalities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis.
AJR. American journal of roentgenology 2006;186(4):1007-12.
2006: manfredi tesauro; WC Thompson; Joel Moss
Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells.
Cell death and differentiation 2006;13(4):597-606.
2006: Eun Hwa Choi; Mary Ehrmantraut; Charles B Foster; Joel Moss; STEPHEN CHANOCK
Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
Pediatric pulmonology 2006;41(3):255-62.
2006: Xiaoyan Shen; Kai-Feng Xu; Qingyuan Fan; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Association of brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) with recycling endosomes during transferrin uptake.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(8):2635-40.
2006: Carmen Citterio; Heather D Jones; Gustavo Pacheco-Rodriguez; Aminul Islam; Joel Moss; Martha Vaughan
Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) in HepG2 cell nuclei.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(8):2683-8.
2006: Shunya Oka; Jiro Kato; Joel Moss
Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase.
The Journal of biological chemistry 2006;281(2):705-13.
2006: Jay H Ryu; Joel Moss; Gerald J Beck; Jar-Chi Lee; Kevin K Brown; Jeffrey T Chapman; Geraldine A Finlay; Eric J Olson; Stephen J Ruoss; Janet R Maurer; Thomas A Raffin; Hannah H Peavy; Kevin McCarthy; Angelo M Taveira-DaSilva; Francis X McCormack; Nilo A Avila; Rosamma M DeCastro; Susan S Jacobs; Mario Stylianou; Barry L Fanburg
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.
American journal of respiratory and critical care medicine 2006;173(1):105-11.
2005: Wendy K Steagall; Angelo M Taveira-DaSilva; Joel Moss
Clinical and molecular insights into lymphangioleiomyomatosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2005;22 Suppl 1():S49-66.
2005: Shaowei Li; Fumiko Takeuchi; Ji-an Wang; Christopher Fuller; Gustavo Pacheco-Rodriguez; Joel Moss; Thomas Darling
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
The Journal of experimental medicine 2005;202(5):617-24.
2005: Arnold S Kristof; Gustavo Pacheco-Rodriguez; Bruno Schremmer; Joel Moss
LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
The Journal of pharmacology and experimental therapeutics 2005;314(3):1134-43.
2005: R Corech; A Rao; Anita Laxova; Joel Moss; Michael J Rock; Z Li; Michael R Kosorok; Mark L Splaingard; Philip M Farrell; Joseph T Barbieri
Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.
Journal of clinical microbiology 2005;43(8):3956-62.
2005: Kaoru Aoki; Jiro Kato; Michael T Shoemaker; Joel Moss
Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Gene 2005;351():83-95.
2005: Kai-Feng Xu; Xiaoyan Shen; Hewang Li; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Interaction of BIG2, a brefeldin A-inhibited guanine nucleotide-exchange protein, with exocyst protein Exo70.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(8):2784-9.
2005: Alessandro Vichi; D Michael Payne; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1).
Proceedings of the National Academy of Sciences of the United States of America 2005;102(6):1945-50.
2005: Nilo A Avila; Andrew J Dwyer; Diane V Murphy-Johnson; Pamela Brooks; Joel Moss
Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size.
AJR. American journal of roentgenology 2005;184(2):459-64.
2005: Alessandro Vichi; Joel Moss; Martha Vaughan
ADP-ribosylation factor domain protein 1 (ARD1), a multifunctional protein with ubiquitin E3 ligase, GAP, and ARF domains.
Methods in enzymology 2005;404():195-206.
2005: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Cytohesin-1: structure, function, and ARF activation.
Methods in enzymology 2005;404():184-95.
2005: Heather D Jones; Joel Moss; Martha Vaughan
BIG1 and BIG2, brefeldin A-inhibited guanine nucleotide-exchange factors for ADP-ribosylation factors.
Methods in enzymology 2005;404():174-84.
2005: Angelo M Taveira-DaSilva; Mario Stylianou; Carolyn J Hedin; Olanda M Hathaway; Joel Moss
Bone mineral density in lymphangioleiomyomatosis.
American journal of respiratory and critical care medicine 2005;171(1):61-7.
2004: Denise Crooks; Gustavo Pacheco-Rodriguez; Rosamma M DeCastro; J Philip McCoy; Ji-an Wang; Fumiyuki Kumaki; Thomas Darling; Joel Moss
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(50):17462-7.
2004: Angelo M Taveira-DaSilva; Mario Stylianou; Carolyn J Hedin; Olanda M Hathaway; Joel Moss
Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone.
Chest 2004;126(6):1867-74.
2004: Edward W Cowen; Antoinette Rabel; Victor Nava; Maria Turner; Joel Moss
Eruptive linear papules on the abdomen of a woman with ascites.
Journal of the American Academy of Dermatology 2004;51(1):75-8.
2004: Philip Ian Padilla; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(9):2752-7.
2003: Angelo M Taveira-DaSilva; Mario Stylianou; Carolyn J Hedin; Arnold S Kristof; Nilo A Avila; Antoinette Rabel; William D Travis; Joel Moss
Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis.
American journal of respiratory and critical care medicine 2003;168(12):1427-31.
2003: Arnold S Kristof; Joanna Marks-Konczalik; Eric M Billings; Joel Moss
Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin.
The Journal of biological chemistry 2003;278(36):33637-44.
2003: Christelle Bourgeois; Ian Okazaki; Eleanor Cavanaugh; Maria Nightingale; Joel Moss
Identification of regulatory domains in ADP-ribosyltransferase-1 that determine transferase and NAD glycohydrolase activities.
The Journal of biological chemistry 2003;278(29):26351-5.
2003: Weiling Xu; Suzy A A Comhair; Shuo Zheng; Shan C Chu; Joanna Marks-Konczalik; Joel Moss; S Jaharul Haque; Serpil C Erzurum
STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation.
American journal of physiology. Lung cellular and molecular physiology 2003;285(1):L137-48.
2003: Linda A Stevens; Christelle Bourgeois; Rita Bortell; Joel Moss
Regulatory role of arginine 204 in the catalytic activity of rat alloantigens ART2a and ART2b.
The Journal of biological chemistry 2003;278(22):19591-6.
2003: Philip Ian Padilla; Min-Ju Chang; Gustavo Pacheco-Rodriguez; Ronald Adamik; Joel Moss; Martha Vaughan
Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2322-7.
2003: Hewang Li; Ronald Adamik; Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).
Proceedings of the National Academy of Sciences of the United States of America 2003;100(4):1627-32.
2003: Elisabetta Meacci; Francesca Nuti; Serena Catarzi; Valeria Vasta; Chiara Donati; Sylvain Bourgoin; Paola Bruni; Joel Moss; Martha Vaughan
Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways.
Biochemistry 2003;42(2):284-92.
2002: Fumiyuki Kumaki; Kazuyo Takeda; Zu-Xi Yu; Joel Moss; Victor J Ferrans
Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis.
American journal of respiratory and critical care medicine 2002;166(2):187-91.
2002: Gregorino Paone; Akihiro Wada; Linda A Stevens; Abul Matin; Toshiya Hirayama; Rodney L Levine; Joel Moss
ADP ribosylation of human neutrophil peptide-1 regulates its biological properties.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(12):8231-5.
2002: Matthew J Riese; Udo-Michael Goehring; Mary E Ehrmantraut; Joel Moss; Joseph T Barbieri; Klaus Aktories; Gudula Schmidt
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
The Journal of biological chemistry 2002;277(14):12082-8.
2002: Nilo A Avila; John A Kelly; Andrew J Dwyer; Dennis L Johnson; Elizabeth C Jones; Joel Moss
Lymphangioleiomyomatosis: correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis.
Radiology 2002;223(1):189-97.
2002: Pingtao Tang; Tammy P Cheng; Davide Agnello; Chang-You Wu; Bruce D Hissong; Wendy T Watford; Hyun-Jong Ahn; Jérôme Galon; Joel Moss; Martha Vaughan; John O'Shea; Massimo Gadina
Cybr, a cytokine-inducible protein that binds cytohesin-1 and regulates its activity.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):2625-9.
2002: Gustavo Pacheco-Rodriguez; Arnold S Kristof; Linda A Stevens; Yi Zhang; Denise Crooks; Joel Moss
Giles F. Filley Lecture. Genetics and gene expression in lymphangioleiomyomatosis.
Chest 2002;121(3 Suppl):56S-60S.
2002: Bruce Banwart; Mark L Splaingard; Philip M Farrell; Michael J Rock; Peter L Havens; Joel Moss; Mary E Ehrmantraut; Dara W Frank; Joseph T Barbieri
Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.
The Journal of infectious diseases 2002;185(2):269-70.
2002: Joel Moss; Martha Vaughan
Cytohesin-1 in 2001.
Archives of biochemistry and biophysics 2002;397(2):156-61.
2002: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
ARF-directed guanine-nucleotide-exchange (GEP) proteins.
Methods in molecular biology (Clifton, N.J.) 2002;189():181-9.
2002: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Methods in enzymology 2002;345():397-404.
2001: Audrey Claing; Wei Chen; William E Miller; Nicolas Vitale; Joel Moss; Richard T Premont; Robert J Lefkowitz
beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis.
The Journal of biological chemistry 2001;276(45):42509-13.
2001: Nilo A Avila; J Bechtle; Andrew J Dwyer; Victor J Ferrans; Joel Moss
Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas.
Radiology 2001;221(2):415-21.
2001: Joel Moss; Rosamma M DeCastro; Nicholas Patronas; A Taveira-DaSilva
Meningiomas in lymphangioleiomyomatosis.
JAMA : the journal of the American Medical Association 2001;286(15):1879-81.
2001: Angelo M Taveira-DaSilva; Carolyn J Hedin; Mario Stylianou; William D Travis; K Matsui; Victor J Ferrans; Joel Moss
Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.
American journal of respiratory and critical care medicine 2001;164(6):1072-6.
2001: Julio C Valencia; K Matsui; C Bondy; J Zhou; A Rasmussen; Kevin J Cullen; Zu-Xi Yu; Joel Moss; Victor J Ferrans
Distribution and mRNA expression of insulin-like growth factor system in pulmonary lymphangioleiomyomatosis.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2001;49(5):421-33.
2001: Joel Moss; Nilo A Avila; PM Barnes; R A Litzenberger; J Bechtle; P G Brooks; Carolyn J Hedin; S Hunsberger; Arnold S Kristof
Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
American journal of respiratory and critical care medicine 2001;164(4):669-71.
2001: Rita Bortell; Joel Moss; R C McKenna; M R Rigby; D Niedzwiecki; Linda A Stevens; W A Patton; John P Mordes; Dale L Greiner; Aldo A Rossini
Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(4):2049-59.
2001: R Bortel; D J Waite; Barbara J Whalen; D Todd; Jean Leif; EA Lesma; Joel Moss; John P Mordes; Aldo A Rossini; Dale L Greiner
Levels of Art2+ cells but not soluble Art2 protein correlate with expression of autoimmune diabetes in the BB rat.
Autoimmunity 2001;33(3):199-211.
2001: K Matsui; William D Travis; R Gonzalez; J A Terzian; J Rosai; Joel Moss; Victor J Ferrans
Association of lymphangioleiomyomatosis (LAM) with endosalpingiosis in the retroperitoneal lymph nodes: report of two cases.
International journal of surgical pathology 2001;9(2):155-62.
2001: K Matsui; M B Beasley; W K Nelson; PM Barnes; J Bechtle; R Falk; Victor J Ferrans; Joel Moss; William D Travis
Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score.
The American journal of surgical pathology 2001;25(4):479-84.
2001: Arnold S Kristof; Joanna Marks-Konczalik; Joel Moss
Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation.
The Journal of biological chemistry 2001;276(11):8445-52.
2001: A Someya; M Sata; Kazuyo Takeda; Gustavo Pacheco-Rodriguez; Victor J Ferrans; Joel Moss; Martha Vaughan
ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(5):2413-8.
2001: Joel Moss; Mary E Ehrmantraut; B D Banwart; Dara W Frank; Joseph T Barbieri
Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus.
Infection and immunity 2001;69(2):1185-8.
2001: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Preparation and assay of recombinant ADP-ribosylation factor-like protein-1 (ARL1).
Methods in enzymology 2001;329():424-8.
2001: Gustavo Pacheco-Rodriguez; Joel Moss; Martha Vaughan
Isolation, cloning, and characterization of brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factor.
Methods in enzymology 2001;329():300-6.
2001: J Kelly; Joel Moss
Lymphangioleiomyomatosis.
The American journal of the medical sciences 2001;321(1):17-25.
2001: Joel Moss
Introduction to symposium: clinical and molecular insights from uncommon lung diseases.
The American journal of the medical sciences 2001;321(1):1-2.
2000: Chen-Yong Lin; P H Huang; W L Liao; Hwai-Jong Cheng; Chun-Fang Huang; J C Kuo; WA Patton; D Massenburg; Joel Moss; Fang-Jen S Lee
ARL4, an ARF-like protein that is developmentally regulated and localized to nuclei and nucleoli.
The Journal of biological chemistry 2000;275(48):37815-23.
2000: K Matsui; W K Riemenschneider; Stephen L Hilbert; Zu-Xi Yu; Kazuyo Takeda; William D Travis; Joel Moss; Victor J Ferrans
Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis.
Archives of pathology & laboratory medicine 2000;124(11):1642-8.
2000: K Matsui; Atsushi Tatsuguchi; Julio C Valencia; Z x Yu; J Bechtle; M B Beasley; Nilo A Avila; William D Travis; Joel Moss; Victor J Ferrans
Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.
Human pathology 2000;31(10):1242-8.
2000: Victor J Ferrans; Zu-Xi Yu; W K Nelson; Julio C Valencia; Atsushi Tatsuguchi; Nilo A Avila; W Riemenschn; K Matsui; William D Travis; Joel Moss
Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2000;67(5):311-29.
2000: N Vitale; V J Ferrans; Joel Moss; Martha Vaughan
Identification of lysosomal and Golgi localization signals in GAP and ARF domains of ARF domain protein 1.
Molecular and cellular biology 2000;20(19):7342-52.
2000: N Vitale; Gustavo Pacheco-Rodriguez; Victor J Ferrans; William K Riemenschneider; Joel Moss; Martha Vaughan
Specific functional interaction of human cytohesin-1 and ADP-ribosylation factor domain protein (ARD1).
The Journal of biological chemistry 2000;275(28):21331-9.
2000: Nilo A Avila; J A Kelly; SC Chu; Andrew J Dwyer; Joel Moss
Lymphangioleiomyomatosis: abdominopelvic CT and US findings.
Radiology 2000;216(1):147-53.
2000: Nicolas Vitale; WA Patton; Joel Moss; Martha Vaughan; Robert J Lefkowitz; Richard T Premont
GIT proteins, A novel family of phosphatidylinositol 3,4, 5-trisphosphate-stimulated GTPase-activating proteins for ARF6.
The Journal of biological chemistry 2000;275(18):13901-6.
2000: manfredi tesauro; WC Thompson; P Rogliani; L Qi; P P Chaudhary; Joel Moss
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2832-5.
2000: R Yamaji; Ronald Adamik; Kazuyo Takeda; A Togawa; Gustavo Pacheco-Rodriguez; Victor J Ferrans; Joel Moss; Martha Vaughan
Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2567-72.
2000: K Matsui; Kazuyo Takeda; Zu-Xi Yu; Julio C Valencia; William D Travis; Joel Moss; Victor J Ferrans
Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.
American journal of respiratory and critical care medicine 2000;161(3 Pt 1):1002-9.
2000: M Ogasawara; S C Kim; Ronald Adamik; A Togawa; Victor J Ferrans; Kazuyo Takeda; M Kirby; Joel Moss; Martha Vaughan
Similarities in function and gene structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation factors.
The Journal of biological chemistry 2000;275(5):3221-30.
2000: Nilo A Avila; Clara C Chen; SC Chu; M Wu; Elizabeth C Jones; R D Neumann; Joel Moss
Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests.
Radiology 2000;214(2):441-6.
2000: K Matsui; Kazuyo Takeda; Zu-Xi Yu; William D Travis; Joel Moss; Victor J Ferrans
Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.
Archives of pathology & laboratory medicine 2000;124(2):267-75.
1999: B Weng; WC Thompson; Hyeoung-Joon Kim; Rodney L Levine; Joel Moss
Modification of the ADP-ribosyltransferase and NAD glycohydrolase activities of a mammalian transferase (ADP-ribosyltransferase 5) by auto-ADP-ribosylation.
The Journal of biological chemistry 1999;274(45):31797-803.
1999: E Balducci; Koji Horiba; J Usuki; M Park; Victor J Ferrans; Joel Moss
Selective expression of RT6 superfamily in human bronchial epithelial cells.
American journal of respiratory cell and molecular biology 1999;21(3):337-46.
1999: Y Matsumoto; Koji Horiba; J Usuki; SC Chu; Victor J Ferrans; Joel Moss
Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.
American journal of respiratory cell and molecular biology 1999;21(3):327-36.
1999: J Rivera-Nieves; WC Thompson; Rodney L Levine; Joel Moss
Thiols mediate superoxide-dependent NADH modification of glyceraldehyde-3-phosphate dehydrogenase.
The Journal of biological chemistry 1999;274(28):19525-31.
1999: Elisabetta Meacci; Valeria Vasta; JP Moorman; DA Bobak; Paola Bruni; Joel Moss; Martha Vaughan
Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity in intact human adenocarcinoma A549 cells.
The Journal of biological chemistry 1999;274(26):18605-12.
1999: N Morinaga; Ronald Adamik; Joel Moss; Martha Vaughan
Brefeldin A inhibited activity of the sec7 domain of p200, a mammalian guanine nucleotide-exchange protein for ADP-ribosylation factors.
The Journal of biological chemistry 1999;274(25):17417-23.
1999: P Konczalik; Joel Moss
Identification of critical, conserved vicinal aspartate residues in mammalian and bacterial ADP-ribosylarginine hydrolases.
The Journal of biological chemistry 1999;274(24):16736-40.
1999: Gustavo Pacheco-Rodriguez; WA Patton; Ronald Adamik; H S Yoo; Fang-Jen S Lee; G F Zhang; Joel Moss; Martha Vaughan
Structural elements of ADP-ribosylation factor 1 required for functional interaction with cytohesin-1.
The Journal of biological chemistry 1999;274(18):12438-44.
1999: A Togawa; N Morinaga; M Ogasawara; Joel Moss; Martha Vaughan
Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
The Journal of biological chemistry 1999;274(18):12308-15.
1999: SC Chu; Koji Horiba; J Usuki; Nilo A Avila; Clara C Chen; William D Travis; Victor J Ferrans; Joel Moss
Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis.
Chest 1999;115(4):1041-52.
1999: M Sata; Joel Moss; Martha Vaughan
Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(6):2752-7.
1999: Joel Moss; Martha Vaughan
Activation of toxin ADP-ribosyltransferases by eukaryotic ADP-ribosylation factors.
Molecular and cellular biochemistry 1999;193(1-2):153-7.
1999: Joel Moss; E Balducci; Eleanor Cavanaugh; Hyeoung-Joon Kim; P Konczalik; EA Lesma; Ian Okazaki; M Park; M Shoemaker; Linda A Stevens; A Zolkiewska
Characterization of NAD:arginine ADP-ribosyltransferases.
Molecular and cellular biochemistry 1999;193(1-2):109-13.
1999: Rita Bortell; T Kanaitsuka; Linda A Stevens; Joel Moss; John P Mordes; Aldo A Rossini; Dale L Greiner
The RT6 (Art2) family of ADP-ribosyltransferases in rat and mouse.
Molecular and cellular biochemistry 1999;193(1-2):61-8.
1999: A Novoradovsky; Mark L Brantly; M A Waclawiw; P P Chaudhary; H Ihara; L Qi; N Tony Eissa; PM Barnes; K M Gabriele; Mary E Ehrmantraut; P Rogliani; Joel Moss
Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency.
American journal of respiratory cell and molecular biology 1999;20(3):441-7.
1999: Ian Okazaki; Joel Moss
Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases.
Annual review of nutrition 1999;19():485-509.
1999: Linda A Stevens; Joel Moss; Martha Vaughan; M Pizza; R Rappuoli
Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors.
Infection and immunity 1999;67(1):259-65.
1998: Elaine M Sloand; Jaroslaw P Maciejewski; D Dunn; Joel Moss; B Brewer; Martha Kirby; Neal S Young
Correction of the PNH defect by GPI-anchored protein transfer.
Blood 1998;92(11):4439-45.
1998: Richard T Premont; Audrey Claing; Nicolas Vitale; Jennifer L R Freeman; Julie A Pitcher; WA Patton; Joel Moss; Martha Vaughan; Robert J Lefkowitz
beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14082-7.
1998: Gustavo Pacheco-Rodriguez; Elisabetta Meacci; N Vitale; Joel Moss; Martha Vaughan
Guanine nucleotide exchange on ADP-ribosylation factors catalyzed by cytohesin-1 and its Sec7 domain.
The Journal of biological chemistry 1998;273(41):26543-8.
1998: J Usuki; Koji Horiba; SC Chu; Joel Moss; Victor J Ferrans
Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status.
Archives of pathology & laboratory medicine 1998;122(10):895-902.
1998: Ian Okazaki; Joel Moss
Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases.
The Journal of biological chemistry 1998;273(37):23617-20.
1998: Joanna Marks-Konczalik; S C Chu; Joel Moss
Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites.
The Journal of biological chemistry 1998;273(35):22201-8.
1998: Joel Moss; Martha Vaughan
Molecules in the ARF orbit.
The Journal of biological chemistry 1998;273(34):21431-4.
1998: S C Tsai; Ronald Adamik; J X Hong; Joel Moss; Martha Vaughan; H Kanoh; J H Exton
Effects of arfaptin 1 on guanine nucleotide-dependent activation of phospholipase D and cholera toxin by ADP-ribosylation factor.
The Journal of biological chemistry 1998;273(33):20697-701.
1998: EA Lesma; Joel Moss; H B Brewer; Rita Bortell; Dale Greiner; John P Mordes; Aldo A Rossini
Characterization of high density lipoprotein-bound and soluble RT6 released following administration of anti-RT6.1 monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(3):1212-9.
1998: S C Chu; Joanna Marks-Konczalik; H P Wu; T C Banks; Joel Moss
Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters.
Biochemical and biophysical research communications 1998;248(3):871-8.
1998: N Vitale; Koji Horiba; Victor J Ferrans; Joel Moss; Martha Vaughan
Localization of ADP-ribosylation factor domain protein 1 (ARD1) in lysosomes and Golgi apparatus.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(15):8613-8.
1998: N Tony Eissa; J W Yuan; C M Haggerty; E K Choo; C D Palmer; Joel Moss
Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7625-30.
1998: J X Hong; Fang-Jen S Lee; WA Patton; Chen-Yong Lin; Joel Moss; Martha Vaughan
Phospholipid- and GTP-dependent activation of cholera toxin and phospholipase D by human ADP-ribosylation factor-like protein 1 (HARL1).
The Journal of biological chemistry 1998;273(25):15872-6.
1998: M Sata; Julie G Donaldson; Joel Moss; Martha Vaughan
Brefeldin A-inhibited guanine nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian ADP ribosylation factors.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(8):4204-8.
1998: A Zolkiewska; WC Thompson; Joel Moss
Interaction of integrin alpha 7 beta 1 in C2C12 myotubes and in solution with laminin.
Experimental cell research 1998;240(1):86-94.
1998: N Vitale; Joel Moss; Martha Vaughan
Molecular characterization of the GTPase-activating domain of ADP-ribosylation factor domain protein 1 (ARD1).
The Journal of biological chemistry 1998;273(5):2553-60.
1997: Fang-Jen S Lee; Chun-Fang Huang; W L Yu; Leh-Miauh Buu; Chen-Yong Lin; M C Huang; Joel Moss; Martha Vaughan
Characterization of an ADP-ribosylation factor-like 1 protein in Saccharomyces cerevisiae.
The Journal of biological chemistry 1997;272(49):30998-1005.
1997: N Morinaga; Joel Moss; Martha Vaughan
Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(24):12926-31.
1997: T Shibutani; T M Johnson; Zu-Xi Yu; Victor J Ferrans; Joel Moss; Stephen E Epstein
Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells.
The Journal of clinical investigation 1997;100(8):2054-61.
1997: N Vitale; Joel Moss; Martha Vaughan
Characterization of a GDP dissociation inhibitory region of ADP-ribosylation factor domain protein ARD1.
The Journal of biological chemistry 1997;272(40):25077-82.
1997: T Kanaitsuka; Rita Bortell; Linda A Stevens; Joel Moss; DF Sardinha; Thiruchandurai V Rajan; Danny Zipris; John P Mordes; Dale L Greiner; Aldo A Rossini
Expression in BALB/c and C57BL/6 mice of Rt6-1 and Rt6-2 ADP-ribosyltransferases that differ in enzymatic activity: C57BL/6 Rt6-1 is a natural transferase knockout.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2741-9.
1997: T Hayashi; M V Fleming; William Stetler-Stevenson; Lance A Liotta; Joel Moss; Victor J Ferrans; William D Travis
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
Human pathology 1997;28(9):1071-8.
1997: Fang-Jen S Lee; WA Patton; Chen-Yong Lin; Joel Moss; Martha Vaughan; ND Goldman; C Syin
Identification and characterization of an ADP-ribosylation factor in Plasmodium falciparum.
Molecular and biochemical parasitology 1997;87(2):217-23.
1997: Hyeoung-Joon Kim; Ian Okazaki; T Takada; Joel Moss
An 18-kDa domain of a glycosylphosphatidylinositol-linked NAD:arginine ADP-ribosyltransferase possesses NAD glycohydrolase activity.
The Journal of biological chemistry 1997;272(14):8918-23.
1997: Elisabetta Meacci; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(5):1745-8.
1997: Joel Moss; Linda A Stevens; Eleanor Cavanaugh; Ian Okazaki; Rita Bortell; T Kanaitsuka; John P Mordes; Dale L Greiner; Aldo A Rossini
Characterization of mouse Rt6.1 NAD:arginine ADP-ribosyltransferase.
The Journal of biological chemistry 1997;272(7):4342-6.
1997: N Vitale; Joel Moss; Martha Vaughan
Interaction of the GTP-binding and GTPase-activating domains of ARD1 involves the effector region of the ADP-ribosylation factor domain.
The Journal of biological chemistry 1997;272(7):3897-904.
1997: Martha Vaughan; Joel Moss
Activation of toxin ADP-ribosyltransferases by the family of ADP-ribosylation factors.
Advances in experimental medicine and biology 1997;419():315-20.
1997: A Zolkiewska; Joel Moss
The alpha 7 integrin as a target protein for cell surface mono-ADP-ribosylation in muscle cells.
Advances in experimental medicine and biology 1997;419():297-303.
1997: Dale L Greiner; S Malkani; T Kanaitsuka; Rita Bortell; J Doukas; M Rigby; Barbara J Whalen; Linda A Stevens; Joel Moss; John P Mordes; Aldo A Rossini
The T cell marker RT6 in a rat model of autoimmune diabetes.
Advances in experimental medicine and biology 1997;419():209-16.
1997: Rita Bortell; M Rigby; L Stevens; Joel Moss; T Kanaitsuka; John P Mordes; Dale Greiner; A Rossini
Mouse RT6 locus 1 and rat RT6.2 are NAD+. Arginine ADP-ribosyltransferases with auto-ADP-ribosylation activity.
Advances in experimental medicine and biology 1997;419():169-73.
1997: Ian Okazaki; Hyeoung-Joon Kim; Joel Moss
Molecular cloning and characterization of lymphocyte and muscle ADP-ribosyltransferases.
Advances in experimental medicine and biology 1997;419():129-36.
1997: Joel Moss; A Zolkiewska; Ian Okazaki
ADP-ribosylarginine hydrolases and ADP-ribosyltransferases. Partners in ADP-ribosylation cycles.
Advances in experimental medicine and biology 1997;419():25-33.
1996: N Morinaga; S C Tsai; Joel Moss; Martha Vaughan
Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(23):12856-60.
1996: N Tony Eissa; A J Strauss; C M Haggerty; E K Choo; SC Chu; Joel Moss
Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines.
The Journal of biological chemistry 1996;271(43):27184-7.
1996: M Ding; N Vitale; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Characterization of a GTPase-activating protein that stimulates GTP hydrolysis by both ADP-ribosylation factor (ARF) and ARF-like proteins. Comparison to the ARD1 gap domain.
The Journal of biological chemistry 1996;271(39):24005-9.
1996: Ian Okazaki; Hyeoung-Joon Kim; Joel Moss
Cloning and characterization of a novel membrane-associated lymphocyte NAD:arginine ADP-ribosyltransferase.
The Journal of biological chemistry 1996;271(36):22052-7.
1996: C M Lee; Linda A Stevens; H C Hsu; S C Tsai; Y T Lee; Joel Moss; Martha Vaughan
Expression in human endothelial cells of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins involved in the initiation of vesicular transport.
Journal of molecular and cellular cardiology 1996;28(9):1911-20.
1996: Ian Okazaki; Hyeoung-Joon Kim; Noel G McElvaney; E Lesma; Joel Moss
Molecular characterization of a glycosylphosphatidylinositol-linked ADP-ribosyltransferase from lymphocytes.
Blood 1996;88(3):915-21.
1996: S R Price; M S Nightingale; M Tsuchiya; Joel Moss; Martha Vaughan
Interspecies relationships among ADP-ribosylation factors (ARFs): evidence of evolutionary pressure to maintain individual identities.
Molecular and cellular biochemistry 1996;159(1):15-23.
1996: M R Rigby; Rita Bortell; Linda A Stevens; Joel Moss; T Kanaitsuka; H Shigeta; John P Mordes; Dale L Greiner; Aldo A Rossini
Rat RT6.2 and mouse Rt6 locus 1 are NAD+: arginine ADP ribosyltransferases with auto-ADP ribosylation activity.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(11):4259-65.
1996: N Vitale; Joel Moss; Martha Vaughan
ARD1, a 64-kDa bifunctional protein containing an 18-kDa GTP-binding ADP-ribosylation factor domain and a 46-kDa GTPase-activating domain.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(5):1941-4.
1996: S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Purification and characterization of a guanine nucleotide-exchange protein for ADP-ribosylation factor from spleen cytosol.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(1):305-9.
1996: Ian Okazaki; Joel Moss
Mono-ADP-ribosylation: a reversible posttranslational modification of proteins.
Advances in pharmacology (San Diego, Calif.) 1996;35():247-80.
1996: Ian Okazaki; Joel Moss
Structure and function of eukaryotic mono-ADP-ribosyltransferases.
Reviews of physiology, biochemistry and pharmacology 1996;129():51-104.
1995: J M Justice; J J Murtagh; Joel Moss; Martha Vaughan
Hydrophobicity and subunit interactions of rod outer segment proteins investigated using Triton X-114 phase partitioning.
The Journal of biological chemistry 1995;270(30):17970-6.
1995: Joel Moss; Martha Vaughan
Structure and function of ARF proteins: activators of cholera toxin and critical components of intracellular vesicular transport processes.
The Journal of biological chemistry 1995;270(21):12327-30.
1995: SC Chu; H P Wu; T C Banks; N Tony Eissa; Joel Moss
Structural diversity in the 5'-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA.
The Journal of biological chemistry 1995;270(18):10625-30.
1995: A Zolkiewska; Joel Moss
Processing of ADP-ribosylated integrin alpha 7 in skeletal muscle myotubes.
The Journal of biological chemistry 1995;270(16):9227-33.
1995: J X Hong; X Zhang; Joel Moss; Martha Vaughan
Isolation of an amino-terminal deleted recombinant ADP-ribosylation factor 1 in an activated nucleotide-free state.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):3056-9.
1995: J M Justice; Michael M Bliziotes; Linda A Stevens; Joel Moss; Martha Vaughan
Involvement of N-myristoylation in monoclonal antibody recognition sites on chimeric G protein alpha subunits.
The Journal of biological chemistry 1995;270(12):6436-9.
1995: T Takada; K Iida; Joel Moss
Conservation of a common motif in enzymes catalyzing ADP-ribose transfer. Identification of domains in mammalian transferases.
The Journal of biological chemistry 1995;270(2):541-4.
1995: G F Zhang; WA Patton; Fang-Jen S Lee; Marek Liyanage; J S Han; Sue Goo Rhee; Joel Moss; Martha Vaughan
Different ARF domains are required for the activation of cholera toxin and phospholipase D.
The Journal of biological chemistry 1995;270(1):21-4.
1995: Ian Okazaki; A Zolkiewska; T Takada; Joel Moss
Characterization of mammalian ADP-ribosylation cycles.
Biochimie 1995;77(5):319-25.
1994: T Murayama; E L Hewlett; N J Maloney; J M Justice; Joel Moss
Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase.
Biochemistry 1994;33(51):15293-7.
1994: D Massenburg; J S Han; Marek Liyanage; WA Patton; Sue Goo Rhee; Joel Moss; Martha Vaughan
Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and 6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(24):11718-22.
1994: Ian Okazaki; A Zolkiewska; M S Nightingale; Joel Moss
Immunological and structural conservation of mammalian skeletal muscle glycosylphosphatidylinositol-linked ADP-ribosyltransferases.
Biochemistry 1994;33(43):12828-36.
1994: L J McDonald; Joel Moss
Enzymatic and nonenzymatic ADP-ribosylation of cysteine.
Molecular and cellular biochemistry 1994;138(1-2):221-6.
1994: L J McDonald; Joel Moss
Nitric oxide and NAD-dependent protein modification.
Molecular and cellular biochemistry 1994;138(1-2):201-6.
1994: Ian Okazaki; Joel Moss
Common structure of the catalytic sites of mammalian and bacterial toxin ADP-ribosyltransferases.
Molecular and cellular biochemistry 1994;138(1-2):177-81.
1994: Catherine Welsh; Joel Moss; Martha Vaughan
ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin.
Molecular and cellular biochemistry 1994;138(1-2):157-66.
1994: T Takada; Ian Okazaki; Joel Moss
ADP-ribosylarginine hydrolases.
Molecular and cellular biochemistry 1994;138(1-2):119-22.
1994: A Zolkiewska; Ian Okazaki; Joel Moss
Vertebrate mono-ADP-ribosyltransferases.
Molecular and cellular biochemistry 1994;138(1-2):107-12.
1994: Fang-Jen S Lee; Linda A Stevens; Linda M Hall; J J Murtagh; Y L Kao; Joel Moss; Martha Vaughan
Characterization of class II and class III ADP-ribosylation factor genes and proteins in Drosophila melanogaster.
The Journal of biological chemistry 1994;269(34):21555-60.
1994: Fang-Jen S Lee; Linda A Stevens; Y L Kao; Joel Moss; Martha Vaughan
Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.
The Journal of biological chemistry 1994;269(33):20931-7.
1994: Catherine Welsh; Joel Moss; Martha Vaughan
Isolation of recombinant ADP-ribosylation factor 6, an approximately 20-kDa guanine nucleotide-binding protein, in an activated GTP-bound state.
The Journal of biological chemistry 1994;269(22):15583-7.
1994: S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Identification of a brefeldin A-insensitive guanine nucleotide-exchange protein for ADP-ribosylation factor in bovine brain.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(8):3063-6.
1994: J X Hong; Randy S Haun; S C Tsai; Joel Moss; Martha Vaughan
Effect of ADP-ribosylation factor amino-terminal deletions on its GTP-dependent stimulation of cholera toxin activity.
The Journal of biological chemistry 1994;269(13):9743-5.
1994: T Takada; K Iida; Joel Moss
Expression of NAD glycohydrolase activity by rat mammary adenocarcinoma cells transformed with rat T cell alloantigen RT6.2.
The Journal of biological chemistry 1994;269(13):9420-3.
1994: Joel Moss; S C Tsai; Martha Vaughan
Activation of cholera toxin by ADP-ribosylation factors.
Methods in enzymology 1994;235():640-7.
1994: Joel Moss; Randy S Haun; S C Tsai; Catherine Welsh; Fang-Jen S Lee; S R Price; Martha Vaughan
Activation of cholera toxin by ADP-ribosylation factors: 20-kDa guanine nucleotide-binding proteins.
Methods in enzymology 1994;237():44-63.
1993: A Zolkiewska; Joel Moss
Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells.
The Journal of biological chemistry 1993;268(34):25273-6.
1993: L J McDonald; Joel Moss
Nitric oxide-independent, thiol-associated ADP-ribosylation inactivates aldehyde dehydrogenase.
The Journal of biological chemistry 1993;268(24):17878-82.
1993: T Takada; K Iida; Joel Moss
Cloning and site-directed mutagenesis of human ADP-ribosylarginine hydrolase.
The Journal of biological chemistry 1993;268(24):17837-43.
1993: Fang-Jen S Lee; Joel Moss
An RNA-binding protein gene (RBP1) of Saccharomyces cerevisiae encodes a putative glucose-repressible protein containing two RNA recognition motifs.
The Journal of biological chemistry 1993;268(20):15080-7.
1993: B C Kunz; K A Muczynski; Catherine Welsh; S J Stanley; S C Tsai; Ronald Adamik; P P Chang; Joel Moss; Martha Vaughan
Characterization of recombinant and endogenous ADP-ribosylation factors synthesized in Sf9 insect cells.
Biochemistry 1993;32(26):6643-8.
1993: Joel Moss; Martha Vaughan
ADP-ribosylation factors, 20,000 M(r) guanine nucleotide-binding protein activators of cholera toxin and components of intracellular vesicular transport systems.
Cellular signalling 1993;5(4):367-79.
1993: L J McDonald; Joel Moss
Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(13):6238-41.
1993: J J Murtagh; Fang-Jen S Lee; P Deak; Linda M Hall; L Monaco; C M Lee; Linda A Stevens; Joel Moss; Martha Vaughan
Molecular characterization of a conserved, guanine nucleotide-dependent ADP-ribosylation factor in Drosophila melanogaster.
Biochemistry 1993;32(23):6011-8.
1993: S C Tsai; Ronald Adamik; Randy S Haun; Joel Moss; Martha Vaughan
Effects of brefeldin A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with Golgi.
The Journal of biological chemistry 1993;268(15):10820-5.
1993: K Mishima; M Tsuchiya; M S Nightingale; Joel Moss; Martha Vaughan
ARD 1, a 64-kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation factor domain.
The Journal of biological chemistry 1993;268(12):8801-7.
1993: Randy S Haun; Joel Moss; Martha Vaughan
Characterization of the human ADP-ribosylation factor 3 promoter. Transcriptional regulation of a TATA-less promoter.
The Journal of biological chemistry 1993;268(12):8793-800.
1993: Randy S Haun; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi.
The Journal of biological chemistry 1993;268(10):7064-8.
1993: Joel Moss; S J Stanley; Martha Vaughan; T Tsuji
Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution.
The Journal of biological chemistry 1993;268(9):6383-7.
1993: I M Serventi; E Cavanaugh; Joel Moss; Martha Vaughan
Characterization of the gene for ADP-ribosylation factor (ARF) 2, a developmentally regulated, selectively expressed member of the ARF family of approximately 20-kDa guanine nucleotide-binding proteins.
The Journal of biological chemistry 1993;268(7):4863-72.
1993: T Murayama; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity.
Biochemistry 1993;32(2):561-6.
1993: Joel Moss; Martha Vaughan
ADP-ribosylation factors: protein activators of cholera toxin.
Progress in nucleic acid research and molecular biology 1993;45():47-65.
1993: L J McDonald; Joel Moss
Pleiotropic effects of nitric oxide on ADP-ribosylation, covalent binding of NAD, and catalytic activity of glyceraldehyde-3-phosphate and aldehyde dehydrogenases.
Transactions of the Association of American Physicians 1993;106():155-61.
1992: Fang-Jen S Lee; Joel Moss; Martha Vaughan
Human and Giardia ADP-ribosylation factors (ARFs) complement ARF function in Saccharomyces cerevisiae.
The Journal of biological chemistry 1992;267(34):24441-5.
1992: Fang-Jen S Lee; Joel Moss; L W Lin
A simplified procedure for hybridization of RNA blots.
BioTechniques 1992;13(6):844-6.
1992: A Zolkiewska; M S Nightingale; Joel Moss
Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(23):11352-6.
1992: L J McDonald; L A Wainschel; N J Oppenheimer; Joel Moss
Amino acid-specific ADP-ribosylation: structural characterization and chemical differentiation of ADP-ribose-cysteine adducts formed nonenzymatically and in a pertussis toxin-catalyzed reaction.
Biochemistry 1992;31(47):11881-7.
1992: S R Price; M S Nightingale; DA Bobak; M Tsuchiya; Joel Moss; Martha Vaughan
Conservation of a 23-kDa human transplantation antigen in mammalian species.
Genomics 1992;14(4):959-64.
1992: K Mishima; S R Price; M S Nightingale; E Kousvelari; Joel Moss; Martha Vaughan
Regulation of ADP-ribosylation factor (ARF) expression. Cross-species conservation of the developmental and tissue-specific alternative polyadenylation of ARF 4 mRNA.
The Journal of biological chemistry 1992;267(33):24109-16.
1992: S C Tsai; Ronald Adamik; Randy S Haun; Joel Moss; Martha Vaughan
Differential interaction of ADP-ribosylation factors 1, 3, and 5 with rat brain Golgi membranes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(19):9272-6.
1992: Randy S Haun; I M Serventi; Joel Moss
Rapid, reliable ligation-independent cloning of PCR products using modified plasmid vectors.
BioTechniques 1992;13(4):515-8.
1992: S R Price; Catherine Welsh; Randy S Haun; S J Stanley; Joel Moss; Martha Vaughan
Effects of phospholipid and GTP on recombinant ADP-ribosylation factors (ARFs). Molecular basis for differences in requirements for activity of mammalian ARFs.
The Journal of biological chemistry 1992;267(25):17766-72.
1992: J Avigan; J J Murtagh; Linda A Stevens; C W Angus; Joel Moss; Martha Vaughan
Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus.
Biochemistry 1992;31(33):7736-40.
1992: Joel Moss; S J Stanley; M S Nightingale; J J Murtagh; L Monaco; K Mishima; H C Chen; K C Williamson; S C Tsai
Molecular and immunological characterization of ADP-ribosylarginine hydrolases.
The Journal of biological chemistry 1992;267(15):10481-8.
1992: J J Murtagh; M R Mowatt; C M Lee; Fang-Jen S Lee; K Mishima; Theodore E Nash; Joel Moss; Martha Vaughan
Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor.
The Journal of biological chemistry 1992;267(14):9654-62.
1992: C M Lee; Randy S Haun; S C Tsai; Joel Moss; Martha Vaughan
Characterization of the human gene encoding ADP-ribosylation factor 1, a guanine nucleotide-binding activator of cholera toxin.
The Journal of biological chemistry 1992;267(13):9028-34.
1992: Randy S Haun; Joel Moss
Ligation-independent cloning of glutathione S-transferase fusion genes for expression in Escherichia coli.
Gene 1992;112(1):37-43.
1992: M W Walker; DA Bobak; S C Tsai; Joel Moss; Martha Vaughan
GTP but not GDP analogues promote association of ADP-ribosylation factors, 20-kDa protein activators of cholera toxin, with phospholipids and PC-12 cell membranes.
The Journal of biological chemistry 1992;267(5):3230-5.
1992: Joel Moss; Martha Vaughan
Activation of cholera toxin by ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins.
Current topics in cellular regulation 1992;32():49-72.
1992: I M Serventi; Joel Moss; Martha Vaughan
Enhancement of cholera toxin-catalyzed ADP-ribosylation by guanine nucleotide-binding proteins.
Current topics in microbiology and immunology 1992;175():43-67.
1992: Catherine Welsh; Joel Moss; Martha Vaughan
ADP-ribosylation factor, a guanine nucleotide-binding protein activator of cholera toxin, is isolated in an activated state when expressed as a fusion protein in Escherichia coli.
Transactions of the Association of American Physicians 1992;105():172-6.
1991: S C Tsai; Randy S Haun; M Tsuchiya; Joel Moss; Martha Vaughan
Isolation and characterization of the human gene for ADP-ribosylation factor 3, a 20-kDa guanine nucleotide-binding protein activator of cholera toxin.
The Journal of biological chemistry 1991;266(34):23053-9.
1991: Fang-Jen S Lee; Joel Moss
Cloning of a Saccharomyces cerevisiae gene encoding a protein homologous to allantoicase of Neurospora crassa.
Yeast (Chichester, England) 1991;7(9):993-5.
1991: Joel Moss; Martha Vaughan
Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteins.
Molecular microbiology 1991;5(11):2621-7.
1991: M Hide; H Ali; S R Price; Joel Moss; Michael A Beaven
GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cells.
Molecular pharmacology 1991;40(4):473-9.
1991: C S Chu; B C Trapnell; J J Murtagh; Joel Moss; W Dalemans; S Jallat; Annick Mercenier; A Pavirani; J P Lecocq; Garry R Cutting
Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.
The EMBO journal 1991;10(6):1355-63.
1991: S C Tsai; Ronald Adamik; M Tsuchiya; P P Chang; Joel Moss; Martha Vaughan
Differential expression during development of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding protein activators of cholera toxin.
The Journal of biological chemistry 1991;266(13):8213-9.
1991: C M Lee; P P Chang; S C Tsai; Ronald Adamik; S R Price; B C Kunz; Joel Moss; E M Twiddy; Randall K Holmes
Activation of Escherichia coli heat-labile enterotoxins by native and recombinant adenosine diphosphate-ribosylation factors, 20-kD guanine nucleotide-binding proteins.
The Journal of clinical investigation 1991;87(5):1780-6.
1991: S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Guanine nucleotide dependent formation of a complex between choleragen (cholera toxin) a subunit and bovine brain ADP-ribosylation factor.
Biochemistry 1991;30(15):3697-703.
1991: M Tsuchiya; S R Price; S C Tsai; Joel Moss; Martha Vaughan
Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells.
The Journal of biological chemistry 1991;266(5):2772-7.
1990: K C Williamson; L A Smith; Joel Moss; Martha Vaughan
Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. Isolation and characterization of a newly recognized form of rhoA.
The Journal of biological chemistry 1990;265(34):20807-12.
1990: Joel Moss; S J Stanley; Rodney L Levine
Inactivation of bacterial glutamine synthetase by ADP-ribosylation.
The Journal of biological chemistry 1990;265(34):21056-60.
1990: JANE HALPERN; Joel Moss
Immunological characterization of guanine nucleotide-binding proteins: effects of a monoclonal antibody against the gamma subunit of transducin on guanine nucleotide-binding protein-receptor interactions.
Molecular pharmacology 1990;37(6):797-800.
1990: S R Price; J J Murtagh; M Tsuchiya; I M Serventi; K P Van Meurs; C W Angus; Joel Moss; Martha Vaughan
Multiple forms of Go alpha mRNA: analysis of the 3'-untranslated regions.
Biochemistry 1990;29(21):5069-76.
1990: M Noda; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein.
Biochimica et biophysica acta 1990;1034(2):195-9.
1990: L Monaco; J J Murtagh; K B Newman; S C Tsai; Joel Moss; Martha Vaughan
Selective amplification of an mRNA and related pseudogene for a human ADP-ribosylation factor, a guanine nucleotide-dependent protein activator of cholera toxin.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(6):2206-10.
1990: DA Bobak; Michael M Bliziotes; M Noda; S C Tsai; Ronald Adamik; Joel Moss
Mechanism of activation of cholera toxin by ADP-ribosylation factor (ARF): both low- and high-affinity interactions of ARF with guanine nucleotides promote toxin activation.
Biochemistry 1990;29(4):855-61.
1990: K C Williamson; L A Smith; Joel Moss; Martha Vaughan
Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids.
Transactions of the Association of American Physicians 1990;103():281-8.
1990: Joel Moss; M Tsuchiya; S C Tsai; Ronald Adamik; DA Bobak; S R Price; M S Nightingale; Martha Vaughan
Structural and functional characterization of ADP-ribosylation factors, 20 kDa guanine nucleotide-binding proteins that activate cholera toxin.
Advances in second messenger and phosphoprotein research 1990;24():83-8.
1989: M Tsuchiya; S R Price; M S Nightingale; Joel Moss; Martha Vaughan
Tissue and species distribution of mRNA encoding two ADP-ribosylation factors, 20-kDa guanine nucleotide binding proteins.
Biochemistry 1989;28(25):9668-73.
1989: M Noda; S C Tsai; Ronald Adamik; DA Bobak; Joel Moss; Martha Vaughan
Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.
Biochemistry 1989;28(19):7936-40.
1989: T D Bahnson; S C Tsai; Ronald Adamik; Joel Moss; Martha Vaughan
Microinjection of a 19-kDa guanine nucleotide-binding protein inhibits maturation of Xenopus oocytes.
The Journal of biological chemistry 1989;264(25):14824-8.
1989: DA Bobak; M S Nightingale; J J Murtagh; S R Price; Joel Moss; Martha Vaughan
Molecular cloning, characterization, and expression of human ADP-ribosylation factors: two guanine nucleotide-dependent activators of cholera toxin.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(16):6101-5.
1989: S R Price; S C Tsai; Ronald Adamik; C W Angus; I M Serventi; M Tsuchiya; Joel Moss; Martha Vaughan
Expression of Go alpha mRNA and protein in bovine tissues.
Biochemistry 1989;28(9):3803-7.
1989: Joel Moss; Martha Vaughan
Guanine nucleotide-binding proteins (G proteins) in activation of adenylyl cyclase: lessons learned from cholera and "travelers' diarrhea".
The Journal of laboratory and clinical medicine 1989;113(3):258-68.
1989: Martha Vaughan; S C Tsai; M Noda; Ronald Adamik; Joel Moss
Participation of a guanine nucleotide-binding protein cascade in cholera toxin activation of adenylate cyclase.
Journal of molecular and cellular cardiology 1989;21 Suppl 1():97-102.
1989: M Noda; B C Kunz; S C Tsai; Ronald Adamik; J J Murtagh; H C Chen; JANE HALPERN; Joel Moss
Isolation and immunological properties of adenosine kinase.
Preparative biochemistry 1989;19(4):351-61.
1989: S C Tsai; Ronald Adamik; Vincent C Manganiello; Joel Moss
Effects of nitroprusside and nitroglycerin on cGMP content and PGI2 formation in aorta and vena cava.
Biochemical pharmacology 1989;38(1):61-5.
1988: Y Kanaho; P P Chang; Joel Moss; Martha Vaughan
Mechanism of inhibition of transducin guanosine triphosphatase activity by vanadate.
The Journal of biological chemistry 1988;263(33):17584-9.
1988: Joel Moss; B E Hom; E L Hewlett; S C Tsai; Ronald Adamik; JANE HALPERN; S R Price; Vincent C Manganiello
Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
Molecular pharmacology 1988;34(3):279-85.
1988: S R Price; M Nightingale; S C Tsai; K C Williamson; Ronald Adamik; H C Chen; Joel Moss; Martha Vaughan
Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(15):5488-91.
1988: M A Lee; R E West; Joel Moss
Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.
The Journal of clinical investigation 1988;82(2):388-93.
1988: Joel Moss; S C Tsai; Ronald Adamik; H C Chen; S J Stanley
Purification and characterization of ADP-ribosylarginine hydrolase from turkey erythrocytes.
Biochemistry 1988;27(15):5819-23.
1988: S C Tsai; Ronald Adamik; Joel Moss; K Aktories
Separation of the 24 kDa substrate for botulinum C3 ADP-ribosyltransferase and the cholera toxin ADP-ribosylation factor.
Biochemical and biophysical research communications 1988;152(3):957-61.
1988: Joseph A Kovacs; JANE HALPERN; J C Swan; Joel Moss; J E Parrillo; Henry Masur
Identification of antigens and antibodies specific for Pneumocystis carinii.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(6):2023-31.
1988: S C Tsai; M Noda; Ronald Adamik; P P Chang; H C Chen; Joel Moss; Martha Vaughan
Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain.
The Journal of biological chemistry 1988;263(4):1768-72.
1988: J J Murtagh; S R Price; K P Van Meurs; C W Angus; Joel Moss; Martha Vaughan
Signal transduction by guanine nucleotide-binding proteins: possible molecular basis for multiple forms of Go alpha mRNA.
Transactions of the Association of American Physicians 1988;101():235-41.
1988: Joel Moss; Martha Vaughan
ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.
Advances in enzymology and related areas of molecular biology 1988;61():303-79.
1987: Paul A Watkins; Y Kanaho; Joel Moss
Inhibition of the GTPase activity of transducin by an NAD+:arginine ADP-ribosyltransferase from turkey erythrocytes.
The Biochemical journal 1987;248(3):749-54.
1987: P P Chang; Joel Moss; E M Twiddy; Randall K Holmes
Type II heat-labile enterotoxin of Escherichia coli activates adenylate cyclase in human fibroblasts by ADP ribosylation.
Infection and immunity 1987;55(8):1854-8.
1987: S C Tsai; Ronald Adamik; Y Kanaho; JANE HALPERN; Joel Moss
Immunological and biochemical differentiation of guanyl nucleotide binding proteins: interaction of Go alpha with rhodopsin, anti-Go alpha polyclonal antibodies, and a monoclonal antibody against transducin alpha subunit and Gi alpha.
Biochemistry 1987;26(15):4728-33.
1987: K P Van Meurs; C W Angus; S Lavu; H F Kung; S K Czarnecki; Joel Moss; Martha Vaughan
Deduced amino acid sequence of bovine retinal Go alpha: similarities to other guanine nucleotide-binding proteins.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(10):3107-11.
1987: JANE HALPERN; P P Chang; S C Tsai; Ronald Adamik; Y Kanaho; R Sohn; Joel Moss; Martha Vaughan
Production of antibodies against rhodopsin after immunization with beta gamma-subunits of transducin: evidence for interaction of beta gamma-subunits of guanosine 5'-triphosphate binding proteins with receptor.
Biochemistry 1987;26(6):1655-8.
1986: S C Tsai; Ronald Adamik; B E Hom; Vincent C Manganiello; Joel Moss
Effects of nitroprusside on the bradykinin responsiveness of human fibroblasts.
Molecular pharmacology 1986;30(3):274-8.
1986: C W Angus; K P Van Meurs; S C Tsai; Ronald Adamik; M C Miedel; Y C Pan; H F Kung; Joel Moss; Martha Vaughan
Identification of the probable site of choleragen-catalyzed ADP-ribosylation in a Go alpha-like protein based on cDNA sequence.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(16):5813-6.
1986: JANE HALPERN; S C Tsai; Ronald Adamik; Y Kanaho; E Bekesi; H F Kung; Joel Moss; Martha Vaughan
Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
Molecular pharmacology 1986;29(5):515-9.
1985: Joel Moss; S C Tsai; P Bruni; Ronald Adamik; Y Kanaho; E L Hewlett; Martha Vaughan
Pertussis toxin-catalyzed ADP-ribosylation of adenylate cyclase. Effects of guanyl nucleotides and rhodopsin.
Developments in biological standardization 1985;61():43-9.
1985: P P Chang; JANE HALPERN; R L Sohn; Y Kanaho; Joel Moss; Martha Vaughan
Coupling of receptors to signal transducing components: use of anti-idiotypic antibodies to map the specific sites of interaction of receptors and guanyl nucleotide-binding proteins.
Transactions of the Association of American Physicians 1985;98():131-5.
1984: S C Tsai; Ronald Adamik; Y Kanaho; E L Hewlett; Joel Moss
Effects of guanyl nucleotides and rhodopsin on ADP-ribosylation of the inhibitory GTP-binding component of adenylate cyclase by pertussis toxin.
The Journal of biological chemistry 1984;259(24):15320-3.
1984: Y Kanaho; S C Tsai; Ronald Adamik; E L Hewlett; Joel Moss; Martha Vaughan
Rhodopsin-enhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase.
The Journal of biological chemistry 1984;259(12):7378-81.
1984: Joel Moss; P Bruni; J A Hsia; S C Tsai; Paul A Watkins; JANE HALPERN; Drusilla L Burns; Y Kanaho; P P Chang; E L Hewlett
Pertussis toxin-catalyzed ADP-ribosylation: effects on the coupling of inhibitory receptors to the adenylate cyclase system.
Journal of receptor research 1984;4(1-6):459-74.
1984: P H Pekala; S R Price; C A Horn; B E Hom; Joel Moss; A Cerami
Model for cachexia in chronic disease: secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L1 adipocytes.
Transactions of the Association of American Physicians 1984;97():251-9.
1982: Joel Moss; Drusilla L Burns; P P Chang; A F Cutilletta; Martha Vaughan
Characterization of the GTP-binding component of the adenylate cyclase system in isolated myocardial muscle cells.
Journal of molecular and cellular cardiology 1982;14 Suppl 3():71-5.
1981: Joel Moss; Vincent C Manganiello; B E Hom; S Nakaya; M Vaughan
Effects of d- and l-propranolol on the responsiveness of human fibroblasts to choleragen and prostaglandin E1.
Biochemical pharmacology 1981;30(11):1263-9.